from Reuters: Health News https://ift.tt/2ToPsyb
FDA flags concerns at Akorn's Amityville plant, shares slip
Generic drugmaker Akorn Inc said on Thursday the U.S. Food and Drug Administration had raised concerns about its manufacturing plant in Amityville, New York, that included a lack of records on the maintenance and cleaning of equipment.
from Reuters: Health News https://ift.tt/2ToPsyb
from Reuters: Health News https://ift.tt/2ToPsyb
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment